期刊文献+

百令胶囊联合调气汤辅助治疗慢性肾衰竭的临床观察 被引量:4

下载PDF
导出
摘要 目的:观察在正规西医治疗基础上,百令胶囊联合调气汤对慢性肾衰竭患者的临床疗效及临床症状生活质量的改善情况。方法:64例接受正规西医治疗的慢性肾衰竭患者随机分为两组,服用百令胶囊联合调气汤组(治疗组)33例,单纯服用百令胶囊组(对照组)31例。治疗前后对两组患者进行横断面研究,记录患者治疗前后的血肌酐值、症状评分和生活质量评分,同时观察患者用药期间的不良反应。结果:两组临床症状评分、血肌酐、生活质量评分等指标均较治疗前明显改善(P<0.05);治疗组治疗后仅生活质量评分中VT、BP两个维度的改善程度优于对照组(P<0.05),其他指标两组比较,差异无统计学意义(P>0.05)。两组临床总有效率比较,差异也无统计学意义(P>0.05)。结论:单纯用百令胶囊或使用百令胶囊联合调气汤治疗慢性肾衰竭患者,均具有改善患者临床疗效、生活质量的效果。
出处 《中国药师》 CAS 2013年第8期1198-1200,共3页 China Pharmacist
  • 相关文献

参考文献4

二级参考文献27

  • 1程庆,于力方,师锁柱,陈香美.冬虫夏草对5/6肾切除大鼠肾脏病理改变的影响[J].中华肾脏病杂志,1994,10(1):30-30. 被引量:47
  • 2陈秀益,刘必成,尹莲芳.微炎症反应状态与终末期肾病[J].临床荟萃,2005,20(12):712-715. 被引量:34
  • 3何立群 郑平东 等.百令胶囊治疗慢性肾衰的动物实验研究[J].上海医院药学,1998,9(2):11-13.
  • 4王素华.SF-36健康调查表的应用.国外医学:社会医学分册,2003,10(2):266-268.
  • 5HEMINGWAY H,STAFFORD M,STANSFELD S,et al.Is the SF-36 a valid measure of change in population health Results from the Whitehall Ⅱ study[J]? BMJ,1997,315(7118):1273-1279.
  • 6SCHLEND E A,ERLEN JUDITH A,DUNBAR J J,et al.Health-related quality of life in chronic disease:a comparison across studies using the MOS SF-36[J].Qual Life Res,1998,7(1):57-65.
  • 7THRUSTON H A.Functional impairment associated with psychological distress and medical severity in rural primary care patients[J].Psychiatr Serv,1998,49(7):951-955.
  • 8NORTHOUSE L L,MOOD D,KERSHAW T,et al.Quality of life of women with recurrent breast cancer and their family members[J].J Clin Oncol,2002,20(19):4050-4064.
  • 9ROTSTEIN Z.Quality of life in multiple sclerosis:development and validation of the 'RAYS' scale and comparison with the SF-36[J].Int J Qual Health Care,2000,12(6):511-517.
  • 10HOBART J C,WILLIAMS L S,MORAN K,et al.Quality of life measurement after stroke:uses and abuse of the SF-36[J].Stroke,2002,33(5):1348-1356.

共引文献502

同被引文献51

  • 1杨劲松,郭春花,杨明.新型钙通道阻滞剂硝苯地平控释片治疗高血压的疗效[J].中国老年学杂志,2014,34(11):3132-3133. 被引量:19
  • 2彭家清.百令胶囊联合海昆肾喜胶囊治疗慢性肾衰竭的临床观察[J].中国药师,2006,9(1):13-14. 被引量:18
  • 3Chen N,Wang W, Huang Y,et al. Community - based study onCKD subjects and the associated risk factors. Nephrol Dial Trans-plant, 2009,24(7) :2117 -2123.
  • 4Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidneydisease in China: a cross 一 sectional survey. Lancet, 2012, 379(9818) :815 -822.
  • 5Nitta K, Nagano N,Tsuchiya K. Fibroblast growth factor 23/klotho axis in chronic kidney disease [J]. Nephron Clin Pract, 2014, 128 ( 1- 2) :1-10.
  • 6Jovanovich AJ ,Chonchol M, Brady CB ,et al. 25-vitamin D, 1,25-vita- min D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD : a veteran population [J]. Clin Nephro1,2014,82( 5 ) :296-303.
  • 7Woo KS,Choi JL, Kim BR,et al. Clinical usefulness of serum cystatin C as a marker of renal function [ J]. Diabetes Metab J, 2014, 38 (4) :278-284.
  • 8Hari P,Sahu J,Sinha A,et al. Effect of enalapril on glomerular filtra- tion rate and proteinuria in children with chronic kidney disease:a ran- domized controlled trial[J].Indian Pediatr,2013,50(10) :923-928.
  • 9王宇.观察海昆肾喜胶囊联合百令胶囊对于慢性肾衰竭非透析患者的临床疗效[J].中国保健营养(下旬刊),2014,(1):391-392.
  • 10金亚.百令胶囊联合羟苯磺酸钙治疗早期糖尿病肾病[J].中国药师,2010,13(3):400-401. 被引量:4

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部